phillip moore m.d

24
9/16/06 NAME: PHILLIP MOORE M.D. TITLE: Professor of Clinical Pediatrics, Step I Department of Pediatrics School of Medicine ADDRESS: UCSF - Box 0544 505 Parnassus Ave. San Francisco, CA 94143-0544 TELEPHONE: (415) 476-8488 FAX: (415) 502-8710 EMAIL: [email protected] DATE OF BIRTH: September 29, 1959 PLACE OF BIRTH: Stockton, CA EDUCATION: 1981 B.S. University of California, Davis, CA 1985 M.D. University of California, San Diego, CA 2004-06 M.B.A. University of California, Irvine, CA – in progress POST DOCTORAL TRAINING: 1985-1986 Internship-pediatrics, University of Washington, Seattle, WA 1986-1988 Residency-pediatrics, University of Washington, Seattle, WA 1989-1992 Fellowship-pediatric cardiology, University of California, San Francisco, CA LICENSURE AND CERTIFICATION: 1985-1989 Washington License Registration # 252-09 0024364 1989- California Registration # G 65161 1992-1995 Massachusetts Registration # 76564 1989 Diplomat, American Board of Pediatrics (#40841) 1992-2003 Diplomat, Cardiology, American Board of Pediatrics (#1056) 1992- California X-ray Supervisor License (# RHC 133667) 2003-2009 Recertification, Cardiology, American Board of Pediatrics (#1056) ACADEMIC APPOINTMENTS: 1988-1990 Clinical instructor in pediatrics, University of Washington, Children's Hospital and Medical Center, Seattle, WA. 1992-1994 Clinical instructor in pediatric cardiology, Harvard Medical School, Boston MA. 1994- 1999 Assistant Clinical Professor of Pediatrics, University of California at San Francisco, San Francisco CA. 1999- Associate Professor of Clinical Pediatrics, University of California at San Francisco, San Francisco CA

Upload: simon23

Post on 06-May-2015

1.381 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: PHILLIP MOORE M.D

9/16/06

NAME: PHILLIP MOORE M.D. TITLE: Professor of Clinical Pediatrics, Step I Department of Pediatrics School of Medicine ADDRESS: UCSF - Box 0544 505 Parnassus Ave. San Francisco, CA 94143-0544 TELEPHONE: (415) 476-8488 FAX: (415) 502-8710 EMAIL: [email protected] DATE OF BIRTH: September 29, 1959 PLACE OF BIRTH: Stockton, CA EDUCATION: 1981 B.S. University of California, Davis, CA 1985 M.D. University of California, San Diego, CA 2004-06 M.B.A. University of California, Irvine, CA – in progress POST DOCTORAL TRAINING: 1985-1986 Internship-pediatrics, University of Washington, Seattle, WA 1986-1988 Residency-pediatrics, University of Washington, Seattle, WA 1989-1992 Fellowship-pediatric cardiology, University of California, San Francisco, CA LICENSURE AND CERTIFICATION: 1985-1989 Washington License Registration # 252-09 0024364 1989- California Registration # G 65161 1992-1995 Massachusetts Registration # 76564 1989 Diplomat, American Board of Pediatrics (#40841) 1992-2003 Diplomat, Cardiology, American Board of Pediatrics (#1056) 1992- California X-ray Supervisor License (# RHC 133667) 2003-2009 Recertification, Cardiology, American Board of Pediatrics (#1056) ACADEMIC APPOINTMENTS: 1988-1990 Clinical instructor in pediatrics, University of Washington, Children's Hospital and Medical Center, Seattle, WA. 1992-1994 Clinical instructor in pediatric cardiology, Harvard Medical School, Boston MA. 1994- 1999 Assistant Clinical Professor of Pediatrics, University of California at San Francisco, San Francisco CA. 1999- Associate Professor of Clinical Pediatrics, University of California at San Francisco, San Francisco CA

Page 2: PHILLIP MOORE M.D

2

2003- Associate Professor of Clinical Pediatrics, joint appointment at the University of California at Davis, Davis CA

2005 Professor of Clinical Pediatrics, University of California at San Francisco, San Francisco CA

ANCILLARY POSITIONS HELD CONCURRENTLY: 1987-1989 Emergency neonatal and pediatric air/ground transport, Airlift Northwest, Children's Hospital and Medical Center, Seattle WA 1992-1994 Assistant in Pediatric Cardiology, The Children's Hospital, Boston, MA 1996-1998 Director, Pediatric Cardiac Catheterization Laboratory, UCSF

Children’s Hospital San Francisco CA. 1998-1999 Director, Pediatric / Congenital Cardiac Catheterization Program,

UCSF – Stanford Hospitals, San Francisco -Stanford, CA. 1999 - Director, Pediatric / Congenital Cardiac Catheterization Program,

UCSF Medical Center, San Francisco CA PROFESSIONAL ACTIVITIES CLINICAL Director Pediatric Cardiac Catheterization Program: For the last 8 years I have administered the pediatric cath lab at UCSF with 8 physicians and 10 nursing staff. Attending interventional cardiologist 3.5 days per week for the last 10 years performing over 300 procedures per year on infants, children, and adults with congenital heart disease while supervising 7 cardiology fellows at various levels of training. Attending pediatric cardiologist managing all medical and post surgical hospitalized pediatric cardiology patients 8 weeks per year for the last 10 years while supervising a team of 4 house staff, fellows, medical students, and nurse clinicians. Attending pediatric cardiologist one day per week in the pediatric cardiology outpatient clinic at UCSF managing both adults and children with congenital heart disease for the last 10 years. PROFESSIONAL ORGANIZATIONS Memberships 1982-1992 American Medical Association 1986- American Academy of Pediatrics 1990-1992 American College of Cardiology 1992- American Heart Association 1994 – 2002 California Society of Pediatric Cardiology 1996- Society for Cardiac Angiography and Interventions (SCA&I) 2003- Western Society of Pediatric Cardiology 2003- Congenital Cardiac Interventional Study Consortium (CCISC) Service to Professional Organizations 1997- Society for Cardiac Angiography Member, Pediatric Interventional and Interventions Cardiology Committee

Page 3: PHILLIP MOORE M.D

3

1998 American Heart Association Research Grant Committee – CA 1998-2000 SCA&I Pediatric Program Committee 2001 California Society of Pediatric Program Committee Cardiology 2003- CCISC Scientific Advisory Board SERVICE TO PROFESSIONAL PUBLICATIONS 1993- Journal of the American College of Cardiology ad hoc referee (6/year) 1994-5 Pediatric Pulmonology ad hoc referee 1995- Circulation ad hoc referee (6/year) 1997 The Western Journal of Medicine ad hoc referee 1998- Catheterization and Cardiovascular Diagnosis ad hoc referee (6/year) 2001-2 The Journal of Pediatrics ad hoc referee 2002- The American Journal of Cardiology ad hoc referee (1/year) INVITED PRESENTATIONS International 1994 Catheter Directed Treatment of Aortic Stenosis, Coarctation and Muscular Ventricular Septal Defect. At the XVI Brazilian Congress of Hemodynamics and Angiography. April 19, 1994, Porto Allegre, Brazil. The Use of Stents in Congenital Heart Disease. At the XVI Brazilian Congress of Hemodynamics and Angiography. April 18, 1994, Porto Allegre, Brazil. 1998 Device Closure of ASD and PDA. 5th Annual Scientific Session, The Philippine Society of Cardiac Catheterization and Intervention. February 21, 1998, Manila, Philippines. Pulmonary Valvuloplasty and Stenting. 5th Annual Scientific Session, The Philippine Society of Cardiac Catheterization and Intervention. February 21, 1998, Manila, Philippines. 2000 Device Closure of Atrial Septal Defects. At the Gachon Cardiovascular

Symposium and Live Demonstration 2000, June 17, 2000, Gil Medical Center, Gachon, Korea. The Use of Stents in Congenital Heart Disease. At the Gachon Cardiovascular Symposium and Live Demonstration 2000, June 17, 2000, Gil Medical Center, Gachon, Korea.

2001 Catheter interventions: moderated poster session chairman. At the 3rd World

Congress of Pediatric Cardiology, May 30th, 2001, Toronto, Canada.

Page 4: PHILLIP MOORE M.D

4

2002 Interventional Treatment of Congenital Heart disease. At the Heart Institute of Viet Nam, April 7, 2002, Ho Chi Minh City, Vietnam.

Diagnosis of Congenital Heart disease in the infant. At the Heart Institute of

Viet Nam, April 7, 2002, Ho Chi Minh City, Vietnam. 2003 MRI in Interventional Cardiology. At the 51st Cardiac Society of Australia

and New Zealand. August 10th, 2003. Adelaide, South Australia. Right ventricular dysfunction: Is stenosis or insufficiency worse? At the 51st

Cardiac Society of Australia and New Zealand. August 12th, 2003. Adelaide, South Australia

Single ventricle Interventions. At the 51st Cardiac Society of Australia and

New Zealand. August 12th, 2003. Adelaide, South Australia. The combined approach: Surgery and Interventions. At the 51st Cardiac

Society of Australia and New Zealand. August 13th, 2003. Adelaide, South Australia

National 1993 Stents and Transvenous Devices for Closure of Septal Defects and Patent Ducti. At theInternaitonal Workshop on Pediatric Cardiothoracic Surgery. November 5 1993, Newport Beach, CA. 1994 Interventional Cardiac Catheterization. At Cardiovascualr Problems in Pediatric Practice: An Update for the Pediatrician and Primary Care Provider. May 3, 1994, The Children's Hospital, Boston MA. Catheter interventions in congenital heart disease. At the ACC's 12th annual Advances in Heart Disease. December 10, 1994, San Francisco CA. 1996 Pediatric Abstract Moderator at the 19th Annual Meeting of the Society for Cardiac Angiography and Interventions, May 16, 1996, Colorado Springs, CO. Pediatric Cardiac Catheterization Update - 1996 -Lecturer. At the American College of Cardiology, Heart House Learning Center. June 10 -12, 1996, Bethesda, MD. 1997 Integrated Management of Congenital Heart Disease: Surgical and Transcatheter. AAP Annual Meeting, Section on Cardiology. November 1, 1997, New Orleans, LO.

Page 5: PHILLIP MOORE M.D

5

1998 Pediatric Applications of Vascular Stenting: Complications. Fireside Panel, American College of Cardiology Scientific Session. March 29, 1998, Atlanta, GA. Interventional Cardiology in Congenital Heart Disease, Chair - oral abstract session, American College of Cardiology Scientific Session. March 29, 1998, Atlanta, GA. Pediatric Cardiac Catheterization Update - 1998 -Lecturer. At the American College of Cardiology, Heart House Learning Center. June 1 -3, 1998, Bethesda, MD.

CardioSEAL secundum atrial septal defect closure: How effective is it? At the 71st Scientific session of the American Heart Association, November 11, 1998, Dallas, TX.

1999 How to use stents in the pediatric patient. At “Meet the Experts” session,

American College of Cardiology Scientific Session. March 8, 1999, New Orleans, LA.

ASD device closure: Investigational or are we simply behind the times? At the Blue Cross of California Medical Policy and Technology Committee meeting. March 18, 1999, Los Angeles, CA. “I blew it…Trials and tribulations of a Pediatric Interventionalist” At the 22nd Annual Society for Cardiac Angiography and Intervention meeting. May 14, 1999, Monterey, CA. Critical Pulmonary Stenosis in the neonate. At Cardiology divisional meeting, Medical College of Georgia, November 4, 1999, Augusta, GA.

2000 Catheter Interventional Closure of Atrial and Ventricular Septal Defects. At the 49 th Annual Scientific Session of the American College of Cardiology, March 14, 2000, Anaheim, CA. Interventional Cardiology in Congenital Heart Disease, Chair - oral abstract session, 49 h Annual Scientific Session of the American College of Cardiology, March 15, 2000, Anaheim, CA. Pediatric Cardiac Catheterization Update - 2000 -Lecturer. At the American College of Cardiology, Heart House Learning Center. June 8 -10, 2000, Bethesda, MD.

2001 Late follow up after the arterial switch repair. Panel discussion at the 50 h

Annual Scientific Session of the American College of Cardiology, March 21, 2001, Orlando FL.

Page 6: PHILLIP MOORE M.D

6

2002 Closure of atrial level shunts: The STARFlex device. At the 14th Utah conference on Pediatric Cardiovascular Disease, The Cliff Lodge, January 21, 2002, Snowbird, UT.

Interventional management of RVOT obstruction. At the 14th Utah

conference on Pediatric Cardiovascular Disease, The Cliff Lodge, January 22, 2002, Snowbird, UT.

New strategies in the management of complex heart disease: Pulmonary

atresia with major aortopulmonary collaterals. At the 14th Utah conference on Pediatric Cardiovascular Disease, The Cliff Lodge, January 22, 2002, Snowbird, UT.

Pulmonary insufficiency: should we be more concerned? At the 25th Annual

Scientific Session of the Society for Cardiac Angiography and Intervention, May 17, 2002, Seattle, WA.

Moderator, Pediatric Oral abstracts. At the 25th Annual Scientific Session of

the Society for Cardiac Angiography and Intervention, May 16, 2002, Seattle, WA.

Pediatric Cardiac Catheterization Update - 2002 –Coarse director. At the

American College of Cardiology, Heart House Learning Center. June 3 -5, 2002, Bethesda, MD.

Hemodynamic evaluation and Interventional catheter therapeutic options for

the failing Fontan. At the Annual Scientific Session of the American Heart Association, November 17, 2002, Chicago, Il.

2004 Contrast Enhanced Invasive Cardiac Imaging: At the Pediatric Advisory

Subcommittee of the Anti-Infective Drugs Advisory Committee of the Food and Drug Administration Center for Drug Evaluation and Research Meeting. February 3rd, 2004. Washington D.C.

Interventions for Post Op Complications in the Neonate with Single Ventricle.

At the Annual Scientific Session of the American College of Cardiology. March 9th, 2004. New Orleans, LA.

MRI guided cardiac catheterizations. At the 27th Annual Society for

Cardiovascular Angiography and Interventions Scientific Sessions . April 30th 2004. San Diego, CA.

The combined approach to complex problems in pediatric cardiology and

cardiac surgery. At the Western Society of Pediatric Cardiology. Saturday September 11, 2004. Napa, CA.

Intermediate Follow-Up of Native and Recurrent Coarctation Stent Repair, Is

Integrated Imaging of the Aortic Arch Necessary? A Multi-Institutional

Page 7: PHILLIP MOORE M.D

7

Study. At the Annual Scientific Session of the American Heart Association, November 19, 2004, New Orleans, LA.

2005 Tetrology of Fallot / Pulmonary Atresia. Have we effected Outcomes?. At the

Annual Scientific Session of the American College of Cardiology. March 7th, 2005. Orlando, FL.

2006 Novel implant radiofrequency energy catheter closure of patent foramen ovale

in swine.. At the Annual Scientific Session of the American College of Cardiology March 13th, Atlanta, GA.

Regional 1994 Balloon dilation of aortic stenosis, a "long term" perspective. At the California Society of Pediatric Cardiology. September 24, 1994, Monterey CA. 1995 Therapeutic techniques in the cardiac cath lab. At Pediatric Grand Rounds, UCSF. February 15, 1995, San Francisco, CA. Aortic stents: Treatment for coarctation? At the California Society of Pediatric Cardiology. September 16, 1995, Coronado, CA. Updates in Cardiology. At Pediatric Grand Rounds, SF General Hospital , September 19, 1995, San Francisco, CA. Aquired heart disease. At Stabilization and Management of the Critically Ill Child. December 2, 1995, San Francisco, CA. 1996 Medical Approach to the Failing Heart. At Pediatric Organ Failure: An Update for Pediatricians. March 23, 1996, San Francisco, CA. Update in Interventional Cardiology. At Pediatric Grand Rounds, UC Davis. April 19, 1996, Sacramento, CA. Critical Aortic Stenosis. At Pediatric Intensive Care Rounds, John Muir Medical Center , May 8, 1996, Walnut Creek, CA. New gadgets in cardiac evaluation and management. At The 29th Annual Advances and Controversies in Clinical Pediatrics. May 17, 1996, San Francisco, CA. Treatment of infants with pulmonary atresia and VSD. At the Pediatric cardiology / cardiac surgery conference. July 5, 1996, Kaiser Permenante, Los Angeles, CA. Device closure of atrial septal defects. At the California Society of Pediatric Cardiology. September 20, 1996, San Francisco, CA.

Page 8: PHILLIP MOORE M.D

8

Catheter directed (non operative) treatment of congenital heart disease. At the UCSF Pediatric Specialties Update . November 7,1996, San Francisco, CA. Congenital heart disease presenting in infancy. At Stabilization and Management of the Critically Ill Child. December 7, 1996, San Francisco, CA. 1997 Rehabilitation of pulmonary arteries in PA/VSD. At the California Society of Pediatric Cardiology. September 19, 1997, Los Angeles, CA. Catheter directed (non operative) treatment of congenital heart disease. At the UCSF Tertiary Care Symposium. September 25, 1997, San Francisco, CA. Review of Interventional Pediatric Cardiac Catheterization. At the UCSF Nursing Conference . October 9, 1997, San Francisco, CA. 1998 Homografts, how good are they ? At the California Society of Pediatric Cardiology. September 18, 1998, Aptos, CA.

Congenital heart disease presenting in infancy. At Stabilization and Management of the Critically Ill Child. December 4, 1998, San Francisco, CA.

1999 The Heart: How does it work ? At the Heart for Heart’s Sake San Francisco chapter meeting. March 25, 1999, San Francisco, CA. Role of interventional catheterization in pulmonary artery reconstructions for pulmonary atresia. At the California Society of Pediatric Cardiology. September 25, 1999, Del Mar, CA.

2000 TOF with major aorto-pulmonary collaterals: Follow up and late interventions. At Congenital Heart Surgery: Challenges for the 21st century. September 8, 2000. San Francisco, CA. Role of cardiac catheterization in determining Fontan vs Two vs 1.5 ventricle repair. At Congenital Heart Surgery: Challenges for the 21st century. September 8, 2000. San Francisco, CA. Interventional Catheterization – Chair. At the California Society of Pediatric Cardiology. September 16, 2000, Napa, CA. The emerging field of interventional cardiology. At the Pediatric Critical Care Nursing Conference. October 19, 2000. Burlingame, CA. Device closure of PDA in adults. At CPMC Adult Cardiology Conference. October 24, 2000. San Francisco, CA.

Page 9: PHILLIP MOORE M.D

9

Pulmonary Atresia / Intact Ventricular Septum. At UCSF pediatric critical care conference. October 25, 2000. San Francisco, CA.

2001 Non surgical treatment of congenital heart disease. Pediatric Grand Rounds, UCSF, July 5th, 2001, San Francisco, CA.

Pulmonary Insufficiency: A new treatment strategy. At the California Society

of Pediatric Cardiology annual meeting. September 8th, 2001, La Jolla, CA. Non surgical treatment of congenital heart disease. Continuing Medical

Education Program, John Muir Medical Center, October 25th, 2001, Walnut Creek, CA.

2002 Atrial Septal Defect / PFO Repair Update. At the UC Davis Cardiology

Conference, July 23, 2002, Sacramento, CA. 2003 Interventional Treatment of Adult Congenital Heart Disease. At UCSF Adult

Cardiology Grand Rounds. January 29, 2003. San Francisco, CA. Interventional Treatment of Congenital Heart Disease: Late (?) Results. At

UCSF Cardiovascular Surgery Monthly Conference. May 1, 2003. San Francisco, CA.

Hypoplastic Left Heart Syndrome: Role of the Interventionalist. At

Hypoplastic Left Heart Symposium . May 2, 2003. UCSF, San Francisco, CA. Percutaneous repair of congenital heart lesions. At San Jose Medical Center

Continuing Education Seminar. September 30th, 2003. San Jose, CA. Patent foramen ovale and atrial septal defect closure: present and future. At

Cardiology Update 2003. October 4th, 2003. Carmel, CA. Percutaneous repair of congenital heart lesions. At Good Samaritan Hospital

Continuing Education Seminar. October 29th, 2003. San Jose, CA 2004 Integration of Surgery and Interventional Catheterization. At the Northern

California Kaiser Pediatric Cardiology Conference. January 9th, 2004. San Francisco, CA.

Right ventricular dynamics. At Single Ventricle Symposium . April 23, 2004.

UCSF, San Francisco, CA. Intracardiac Communications: Closures. At the Critical Care Cardiology

Conference. August 20, 2004. San Francisco, CA.

Page 10: PHILLIP MOORE M.D

10

2005 Percutaneous Repair Of Congenital Heart Lesions In Adults. At Cardiology Grand Rounds. Salinas Valley Memorial Hospital. April 22, 2005. Salinas, CA.

When to close a PFO? At the Cardiology Update 2005, August 20th, 2005.

San Francisco, CA Non Surgical Treatment of Congenital Heart Disease. At Pediatric Grand

Rounds, September 22, 2005. UCSF Medical Center, San Francisco, CA 2006 Update on Interventional Treatment of Congenital Heart Disease in Adults.

At Cardiology Grand Rounds , February 15, 2006, UCSF Medical Center, San Francisco, CA

Congenital Pulmonary Artery Stenosis. At Pulmonary Grand Rounds, May 2,

2006, , UCSF Medical Center, San Francisco, CA CME COURSES ATTENDED 1992 – 2005 American College of Cardiology, Scientific Session 1998, 2002, 2004 American Heart Association ,Scientific Session 1996 -2004 Society for Cardiac Angiography and Intervention , Scientific

Session 1994- 2002 California Society of Pediatric Cardiology Annual Session 2002-2004 Western Society of Pediatric Cardiology Annual Session 1997, 2001 American Academy of Pediatrics, Scientific Session 1996,98,2000,02 American College of Cardiology Heart House Interventional

Session GOVERNMENT AND OTHER PROFESSIONAL SERVICE General

1996 California Children's Services subcommittee "Interventional catheterization Standards" – member

2004 Pediatric Advisory Subcommittee of the Anti-Infective Drugs Advisory

Committee of the Food and Drug Administration Center for Drug Evaluation and Research - Consultant

UNIVERSITY AND PUBLIC SERVICE UNIVERSITY SERVICE School of Medicine

2000- Admissions Committee 2004 - Contracting Committee

Page 11: PHILLIP MOORE M.D

11

Department of Pediatrics 1995 - Pediatric Quality Assurance Committee TEACHING AND MENTORING INFORMAL TEACHING (past 5 years) Cardiology ward attending -8 weeks / year - daily teaching rounds with team Angiography conference (2 of 4 Wednesdays / month) Journal Club (3 Wednesdays / year) Cardiology Clinical Conference (weekly) Catheterization Conference (weekly) Catheterization laboratory (2.5 days / week) Cardiology outpatient clinic (1/2 day / week) Pre surgical conference (weekly) Summary of Teaching Hours Last (July 2002 to June 2003): 950 hours Current (July 2003 to June 2004): 950 hours Next (July 2004 to June 2005): 950 hours MENTORING

A. Clinical 4th year Pediatric Cardiology Interventional Fellowship

I train a 4th year pediatric cardiology fellow yearly in congenital interventional cardiac catheterization techniques and clinical / applied research skills.

YEAR NAME STATUS

2005 P Pham In training

2004 I. Kawadji M.D. Pediatric Cardiologist, Kaiser Southern CA

2003 K. Travedi M.D. Assistant Professor, University of Arizona Health Sciences Center, Tucson AZ

2002 D Turner M.D. Assistant Professor, University of Michigan, Detroit, MI

2001 M. Bisheon Pediatric Cardiac Interventionalist, l'Institut de Cardiologie de Montréal,

Page 12: PHILLIP MOORE M.D

12

Canada

2000 M Vranicar M.D. Associate Professor, University of Kentucky, Lexington, KY

1999 Z Amin M.D. Associate Professor, University of Nebraska, Omaha , NE

1998 J Simpson M.D. Registrar, Guys Hospital, London

1997 C Owada M.D. Pediatric Cardiac Interventionalist, Valley Children’s Hospital, Fresno, CA

1996 G Burch M.D. Associate Professor, Oregon Health Sciences University, Portland, OR

B. Research mentoring in applied physiology / interventional research

Research fellows occasionally come and spend 1 to 2 years training in my lab in conjunction with Dr. Higgins, cardiac MRI radiology.

2003 S Schalla Adult Cardiology, Berlin Germany

2001-2002 T Kuehne Pediatric Cardiology, Heart Institute, Berlin, Germany

RESEARCH AND CREATIVE ACTIVITY

RESEARCH AWARDS AND FUNDING Current: Boston Scientific/ Boston Children’s Hospital - Protocol approval pending. Per patient reimbursement for cutting balloon protocol. $3,000./patient – expect 5 to 10 patients enrolled in 2004-2005. Pending: W. L. Gore and Associates – Protocol number A7276-16580-01-03 – Evaluation of a prosthetic catheter implantable stented valve in the right ventricular outflow tract using MRI guidance for treatment of pulmonary insufficiency. $13,000 for 2003. – placed on hold by University due to legal contract issues. Past: Nitinol Medical Technologies Inc. - Protocol # G960098 - Multicenter ASD device closure trial - $830.00/patient . $75,000 since initial grant began in 1997.

Page 13: PHILLIP MOORE M.D

13

Children’s Health Initiative – Protocol A7276-16580-01-01 – Effects of insufficiency and stenosis on ventricular function. New techniques in interventional suturing. $50,000 - 1998 to 2000. UCSF Academic Senate Grant – Use of .052” coils for closure of Patent Ductus Arteriosus. $15,000 – 1997.

PEER REVIEWED PUBLICATIONS: Original Reports: 1. Barth RA, Filly RA, Goldberg JD, Moore P, Silverman NH. Conjoined twins:

Perinatal diagnosis and assessment of associated malformations. Radiol 1990; 177: 201-207.

2. Velvis H, Moore P, Heymann MA. Prostaglandin inhibition prevents the fall in pulmonary vascular resistance as a result of rhythmic distention of the lungs in fetal lambs. Pediatr Res 1991; 30: 62-68.

3. Chang J, Moore P, Fineman JR, Soifer SJ, Heymann MA. Potassium channel pulmonary vasodilation in fetal lambs: role of endothelium-derived nitric oxide. J Appl Physiol 1992, 73(1):188-194.

4. Moore P, Velvis H, Fineman JR, Soifer SJ, Heymann MA. EDRF inhibition attenuates the increase in pulmonary blood flow due to oxygen ventilation in fetal lambs. J Appl Physiol 1992, 73(5):2151-2157.

5. Moore P, Adatia I, Spevak PJ, Keane JF, Perry SB, Castaneda AR, Lock JE. Severe congenital mitral stenosis in infants. Circulation 1994, 89:2099-2106.

6. Verma R, Lock BG, Perry SB, Moore P, Keane JF, Lock JE. Intraaortic spring coil loops; early and late results. JACC 1995, 25:1416-1419.

7. Adatia I, Perry SB, Landzberg M, Moore P, Thompson JE, Wessel DL. Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation. JACC 1995, 25: 1656-1664.

8. Bernstein H, Moore P, Stanger P, Silverman N. Levo-atrial cardinal vein: Morphology and echocardiographic identification of the pulmonary-systemic connection. JACC 1995, 26:995-1001.

9. Moore P, Egito E, Mowrey H, Perry SB, Lock JE, Keane JF. Mid - term results of balloon dilation of congenital aortic stenosis: Predictors of success. JACC 1996, 27: 1257-63.

Page 14: PHILLIP MOORE M.D

14

10. McElhinney DB, Reddy VM, Moore P, Hanley FL. Revision of previous Fontan connections to extracardiac or intraatrial conduit cavopulmonary anastomosis. Ann Thorac Surg 1996, 62:1276-83.

11. Reddy VM, McElhinney DB, Moore P, Petrossian E, Hanley FL. Pulmonary artery growth after bidirectional cavopulmonary shunt: Is there a cause for concern ? J Thorac Cardiovasc Surg 1996; 112:1180-92.

12. Egito E, Moore P, O'Sullivan J, Colan S, Perry SB, Lock JE, Keane JF. Transvascular balloon dilation for neonatal critical aortic stenosis. Early and midterm results. JACC 1997; 29:442-7.

13. McElhinney DB; Mishaly DA; Moore P; Brook MM; Reddy VM; Hanley FL. Isolated left superior vena cava to the left atrium with situs solitus and dextrocardia: extracardiac repair facilitated by juxtaposition of the atrial appendages. American Journal of Cardiology, 1997; 80(10):1379-81.

14. Reddy VM; Petrossian E; McElhinney DB; Moore P; Teitel DF; Hanley FL. One-stage complete unifocalization in infants: when should the ventricular septal defect be closed? Journal of Thoracic and Cardiovascular Surgery, 1997; 113(5):858-66; discussion 866-8.

15. Adatia I, Moore P, Jonas RA, Colan SD, Lock JE, Keane JF. Clinical course and hemodynamic observations following supra annular mitral valve replacement in infants and children. JACC 1997;29:1089-94.

16. McElhinney DB; Reddy VM; Moore P; Hanley FL. Bilateral branch pulmonary artery obstruction due to kinking at insertion sites of bilateral ductus arteriosus.Annals of Thoracic Surgery, 1997; 64(2):537-9.

17. Kohl T, Szabo Z, Suda K, Petrossian E, Ko E, Kececioglu D, Moore P, Silverman NH, Harrison MR, Chou TM, et al. Fetoscopic and open transumbilical fetal cardiac catheterization in sheep. Potential approaches for human fetal cardiac intervention. Circulation, 1997 Feb 18, 95(4):1048-53.

18. Reddy VM, McElhinney DB, Moore P, Haas GS, Hanley FL. Outcomes after bidirectional cavopulmonary shunt in infants less than six months old. JACC 1997; 29: 1365-70.

19. McElhinney DB; Reddy VM; Moore P; Hanley FL. Bidirectional cavopulmonary shunt in patients with anomalies of systemic and pulmonary venous drainage. Annals of Thoracic Surgery, 1997 Jun, 63(6):1676-84.

20. Phoon CK, Van Son J, Moore P, Brook MM, Hass GS, Higgins CB. Anomalous left coronary artery arising from the right sinus of valsalva with a right coronary arteriovenous malformation. Pediatric Cardiology 1997; 18: 385-388.

Page 15: PHILLIP MOORE M.D

15

21. McElhinney DB, Reddy VM, Hanley FL, Moore P. Systemic venous collateral channels causing desaturation after bidirectional cavopulmonary anastomosis: Evaluation and management. JACC 1997; 30: 817-824.

22. Owada C, Teitel D, Moore P. Evaluation of Gianturco coils for closure of large (> 3.5 mm) patent ductus arteriosus. JACC 1997; 30:1856-1862.

23. Abdurrahman L, Adatia I, Mayer JE, Moore P, Treves ST. Acute pulmonary embolism in a neonate: Precipitation during cardiac catheterization and successful treatment. Pedaitric Cardiology 1998; 19:431-435.

24. Petrossian E, McElhinney DB, Reddy VM, Moore P, Parry AJ, Thompson L, Hanley FL. Early results of the extracardiac conduit Fontan operation. Journal of Thoracic and Cardiovascular Surgery, 1999 Apr, 117(4):688-96.

25. Pitlick PT, Anthony CL, Moore P, Shifrin RY, Rubin GD. Three -dimentional visualization of recurrent coarctation of the aorta, using Ultrafast CT and MRI. Circulation 1999, 99:2086-87.

26. Thompson, LD; Petrossian, E; McElhinney, DB; Abrikosova, NA; Moore, P; Reddy,VM; Hanley, FL. Is it necessary to routinely fenestrate an extracardiac fontan? JACC, 1999 34(2):539-44.

27. McElhinney, DB; Reddy, VM; Pian, MS; Moore, P; Hanley, FL. Compression of the central airways by a dilated aorta in infants and children with congenital heart disease. Annals of Thoracic Surgery, 1999 Apr, 67(4):1130-6.

28. Tworetzky W, Moore P, Bekker JM, Bristow JE, Black SM, Fineman JR. Pulmonary blood flow alters nitric oxide production in patients undergoing ASD device closure. JACC 2000, 35(2):463-467.

29. Tworetzky W, Teitel DF, Moore P. Balloon coarcplasty in infants after surgery for hypoplastic left heart syndrome. Cathet. Cardiovasc Intervent.2000, 50:54-58.

30. McElhinney DB, Reddy VM, Petrossian E, Hanley FL, Moore P. Incidence and implications of systemic to pulmonary collateral arteries after bi-directional cavopulmonary anastomosis. Annals of Thoracic Surgery, 2000, 69 (4) 1222-89.

31. Amin, Z.; McElhinney, D. B.; Moore, P.; Reddy, V. M.; Hanley, F. L. Coronary arterial size late after the atrial inversion procedure for transposition of the great arteries: implications for the arterial switch operation. J Thorac Cardiovasc Surg 2000, 120(6): 1047-52.

32. Reddy, VM; McElhinney, DB; Amin, Z; Moore, P; Parry, AJ; Teitel, DF; Hanley,FL. Early and intermediate outcomes after repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries: experience with 85 patients.Circulation, 2000 Apr 18, 101(15):1826-32.

Page 16: PHILLIP MOORE M.D

16

33. Ussia GP, Momenah TS, Ursell P, Brook MM, Moore P, DeLuca F, Silverman N. Evaluation of the morphology of the fossa ovale for placement of devices. Cardiol Young, 2000; 10:502-509.

34. Momenah TS, McElhinney DB, Brook MM, Moore P, Silverman N. Transesophageal echocardiographic predictors for successful transcatheter closure of defects within the oval fossa using the STARflex septal occlusion device. Cardiol Young, 2000; 10:510-518.

35. Amin, Z.; McElhinney, D. B.; Reddy, V. M.; Moore, P.; Hanley, F. L.; Teitel, D. F. Coronary to pulmonary artery collaterals in patients with pulmonary atresia and ventricular septal defect. Ann Thorac Surg, 2000; 70(1): 119-23.

36. Simpson JM, Moore P, Teitel DF. Cardiac catheterization of low birth weight infants. Am J Cardiol. 2001;87:1372-7.

37. Tworetzky W, Bristow JE, Moore P, Book MM, Segal RM, Brasch RC, Hawgood S, Fineman JR. Inhaled nitric oxide in neonates with persistent pulmonary hypertension. Lancet, 2001; 357: 118-119.

38. Kuehne T, Saeed M, Reddy G, Akbar H, Gleason K, Turner D, Teitel DF, Moore P, Higgins C. Sequential MR monitoring of pulmonary flow with endovascular stents placed across the pulmonary valve in growing swine. Circulation 2001, 104: 2363-2368.

39. Vranicar M, Teitel D, Moore P. Use of small stents for rehabilitation of hypoplastic pulmonary arteries in pulmonary atresia with ventricular septal defect. Catheter Cardiovasc Interv. 2002, 55 (1), 78-82.

40. Kuehne T, Saeed M, Reddy G, Akbary H, Gleason K, Teitel DF, Moore P, Higgins C. The influence of blood pool contrast media on MR imaging and flow measurements in the presence of pulmonary artery stents in swine. Radiology –2002; 223(2): 439-45.

41. Feinstein JA, Moore P, Rosenthal DN, Puchalski M, Brook MM. Comparison of contrast echocardiography versus cardiac catheterization for detection of pulmonary arteriovenous malformations. Am J Cardiol. 2002;89(3):281-5.

42. Rodefeld M, Suleman S, Thompson L, Moore P, Teitel DF, Reddy, MV, Hanley, FH. Selective use of surgical aortopulmonary window in pulmonary atresia patients with poorly developed aortopulmonary collaterals and hypoplastic pulmonary arteries. The Journal of Thoracic and Cardiovascular Surgery. 2002: 123(6) 1147-54.

43. Kuehne T, Saeed M, Higgins CB, Gleason K, Krombach GA, Weber O, Martin A, Turner D, Teitel DF, Moore P. MRI guided deployment and post-interventional assessment of endovascular stents in the pulmonary position in swine. Radiology,.2003: 226(2) 475-81.

Page 17: PHILLIP MOORE M.D

17

44. Amin Z, Danford DA, Gremmels D, Schamberger M, Williams WG, Forbes TJ, Strawn J, Reddy VM, Duncan KF, Moore P, Hanley FL. Determinants of acute homograft failure in the right ventricular outflow tract: a multi-institutional study. Accepted in Thoracic and Cardiovascular surgery, Accepted 10/ 2002.

45. Kung, G. C., P. Moore, McElhinney DB, Teitel DF.. (2003). Retrograde Transcatheter Coil Embolization of Congenital Coronary Artery Fistulas in Infants and Young Children. Pediatr Cardiol.2003:24(5)448-53.

46. Thompson J, Moore P, Teitel D F. Pulmonary venous wedge pressures accurately predict pulmonary arterial pressures in children with single ventricle physiology. Pediatric Cardiol 2003:24(6)531-7.

47. Forbes T J, Rodriguez-Cruz E, Amin Z, Benson LN, Fagan TE, Hellenbrand W E, Latson LA, Moore P, Mullins CE, Vincent, J A. The Genesis Stent: A New, Low Profile Stent for Use in Infants, Children, and Adults with Congenital Heart Disease. Catheter and Cardiovasc Interv 2003; 59(3): 406-14.

48. Kuehne T, Saeed M, Gleason K, Turner D, Teitel DF, Higgins CB, Moore P. The Effects of Pulmonary Insufficiency on Biventricular Pump and Muscle Function in the Developing Heart of Young Growing Swine. Circulation 2003; 108: 2007-13.

49. Schalla S, Saeed M, Higgins CB, Martin A, Weber O, Moore P. Magnetic Resonance guided cardiac catheterization in a swine model of atrial septal defect. Circulation. 2003; 108:1865-70.

50. Weber OM, Schalla S, Martin AJ, Saeed M, Lee R, Shunk KA, Moore P, Higgins CB. Interventional cardiac magnetic resonance imaging. Semin Roentgenol. 2003 Oct;38(4):352-7.

51. Kuehne T, Yilmaz S, Meinus C, Moore P, Saeed M, Weber O, Higgins CB, Blank T, Elsaesser E, Schnackenburg B, Ewert P, Lange PE, Nagel E. Magnetic resonance imaging-guided transcatheter implantation of a prosthetic valve in aortic valve position: Feasibility study in swine. J Am Coll Cardiol. 2004, 44(11):2247-9.

52. Kuehne T, Yilmaz S, Steendijk P, Moore P, Groenink M, Saaed M, Weber O,

Higgins CB, Ewert P, Fleck E, Nagel E, Schulze-Neick I, Lange P. Magnetic resonance imaging analysis of right ventricular pressure-volume loops:in vivo validation and clinical application in patients with pulmonary hypertension. Circulation. 2004, 110(14):2010-6. Epub 2004 Sep 27.

53. Giardini A, Moore P, Brook M, Stratton V, Tacy T. Effect of Transcatheter Atrial Septal Defect Closure in Children on Left Ventricular Diastolic Function [rapid communication]. JACC 2005:10: 1255-57.

54. Schalla S, Saeed M, Higgins C B, Weber O, Martin A, Moore P. Balloon sizing

and transcatheter closure of acute atrial septal defects guided by magnetic

Page 18: PHILLIP MOORE M.D

18

resonance fluoroscopy: assessment and validation in a large animal model. J Magn Reson Imaging. 2005 Mar;21(3):204-11.

55. Moore P. MRI guided congenital cardiac catheterization and intervention: the

future? Catheter Cardiovasc Interv. 2005 Sep;66(1):1-8.

Accepted for Publication/In Press

56. Kuehne T, Gleason K Saeed M, Turner D, Teitel DF, Higgins CB, Moore P. Effects of Pulmonary Insufficiency and Stenosis on Biventricular Function in the Developing Heart of Young Growing Swine. Journal of Applied Physiology 2005

In Preparation / Submitted for Publication Pujadas S, Reddy GP, Weber O, Tan C, Moore P, Higgins CB, Feasibility of

Velocity-Encoded Cine MR imaging to measure changes in collateral blood flow after stenting of aortic coarctation.

Forbes T, Moore P, Amin Z, Zahn E, Hijazi Z, Cheatham J, Hagler D, Ebeid M,

Sievert H, Quereshi S, Fagan T, Hellenbrand W. Congenitial Cardiovascular Interventional Study Consortium (CCISC ). Immediate Complications Associated with Stenting Native and Recurrent Coarctation of the Aorta: A Multi-Institutional Study.

Roberta L. Keller, Phillip Moore, David Teitel, Samuel Hawgood,, John McQuitty, Jeffrey R. Fineman. Abnormal vascular tone in infants and children with lung hypoplasia: findings from cardiac catheterization and the response to chronic therapy

Reviews and Chapters:

1. Moore P, Soifer SJ: Aquired heart disease. In: Holbrook PR (ed), Textbook of

Pediatric Critical Care. W.B. Saunders Co., Philiadelphia. 1992.

2. Moore P, Fyler DC: Cardiac neoplasms and other intracardiac masses. In: Gellis SS and Kagan BM (eds), Current Pediatric Therapy 15th edition. W. B. Saunders Co., Philidelphia. 1996.

3. Brook MM, Moore P, Van Hare GF: Circulation. In: Rudolph AM, Kamei RK (eds), Rudolph’s Fundamentals of Pediatrics, 2nd edition. Appleton and Lange, Stamford, Connecticut. 1998.

4. Moore P, Humes R: Complex Tetrologies (Ch 5). In ACC PACSAPP Congenital Heart Disease, First edition. ACC, Bethesda, Maryland, 1998.

Page 19: PHILLIP MOORE M.D

19

5. Moore P, Lock JE: Catheter intervention: Balloon angioplasty. In Diagnostic and Interventional Catheterization in Congenital Heart Disease, Kluwer Academic Publishers, Boston Massachusetts, 2000.

6. Feinstein J, Moore P: Cardiac catheterization, angiography and interventional procedures. In Congenital Cardiac Surgery, McGraw-Hill Publishing, New York, 2002.

7. Brook MM, Heymann MA, Moore P: Patent ductus arteriosus. In Heart Disease in Infants, Children, and Adolescents, 6th edition, Williams and Wilkins, Baltimore Maryland, 2001.

8. Brook MM, Moore P, Van Hare GF: Circulation. In: Rudolph AM, Kamei RK (eds), Rudolph’s Fundamentals of Pediatrics, 3rd edition. Appleton and Lange, Stamford, Connecticut. 2001.

9. Heymann MA, Moore P: Obstructive Lesions. In: Hoffman JIE, Rudolph CD (eds), Rudolph’s Pediatrics, 21st edition. Appleton and Lange, Stamford, Connecticut. 2001.

10. Feinstein JA, Moore P: Cardiac Catheterization. In: Hoffman JIE, Rudolph CD (eds), Rudolph’s Pediatrics, 21st edition. Appleton and Lange, Stamford, Connecticut. 2001.

11. Weber OM, Saeed M, Martin AJ, Moore P, Higashida R, Schalla S, Kuehne T, Lee R, Higgins CB: Early Experience with Combined MR&X-ray Suites. In: Fayad Z, and Al Lardo (eds), Cardiovasular Magnetic Resonance: Established and Emerging Applications. In press 2003.

12. Moore P, Khanh HT, Chuan ZS,, Teitel D: Percutaneous Interventions in Adults with Congenital Heart Diseases. In: Nguyen T, King S, Grines C, Palacios I, Hu D and Saito S (eds), Practical Handbook of Advanced Interventional Cardiology, Second edition. Blackwell Futura, Elmsford, NY. 2003.

Abstracts: 1. Moore P, Velvis H, Heymann MA. EDRF inhibition blocks the pulmonary

vasodilatory response to ventilation with oxygen in fetal lambs. Pediatr Res 1991, 29(4) part 2:1453.

2. Moore P, Velvis H, Heymann MA. The effects of EDRF inhibition on resting pulmonary vascular tone in fetal lambs. Pediatr Res 1991, 29(4) part 2:1453.

3. Moore P, Spevak PJ, Keane JF, Perry SB, Lock JE. Results of balloon dilation for congenital mitral stenosis in infants. J Am Coll Cardiol 1993, 21(2) supplement A: 445A.

4. Moore P, Jonas R, Perry SB, Lock JE, Keane JF. Surgery following balloon dilation of valvar aortic stenosis beyond infancy. J Am Coll Cardiol 1993, 21(2) supplement A: 80A.

Page 20: PHILLIP MOORE M.D

20

5. Brook MM, Moore, P. Comparison of echocardiographic and angiographic measurement of patent ductus arteriosus and implications for coil closure. J Am Soc Echocardiogr 1996;9(3):388.

6. Chou, T.M., Shu, X.H., Ko, E., Zellner, C., Lee, T.M., Sudhir, K., Brook, M., Moore, P.: Intravascular ultrasound guided coil closure of patentductus in infants and children. The Society for Cardioac Angiography and Interventions annual meeting and Melvin P. Judkins Cardiac Imaging Symposium, Scottsdale, Arizona, May 17, 1997, P32: 12.

7. Owada CY, Moore P. Transcatheter occlusion of large (>3.5 mm) patent ductus arteriosus- application and limitation of standard .038 and .052 Gianturco coils. The Society for Cardioac Angiography and Interventions annual meeting and Melvin P. Judkins Cardiac Imaging Symposium, Scottsdale, Arizona, May 17, 1997.

8. Sperazza C, Reddy M, Hanley F, Moore P: Distal pulmonary vessel growth in infants with pulmonary atresia and VSD. JACC 1998; 31: 466A. American College of Cardiology 47th Annual Scientific Session, Atlanta, Georgia, April 1, 1998.

9. Owada C, Teitel DF, Moore P. A new controlled release system for standard .052” and .038” Gianturco coils. JACC 1998; 31: 152A. American College of Cardiology 47th Annual Scientific Session, Atlanta, Georgia, May 30, 1998.

10. Burch GH, McElhinney DB, Hanley FL, Teitel DF, Moore P. Coil embolization of intralobar pulmonary sequestration: Immediate and mid term results. American Academy of Pediatrics Annual Meeting, San Francisco, California, October 16, 1998.

11. Tworetzky, W, Moore P, Bristow JE, Fineman JR. Pulmonary blood flow-mediated changes in endothelial-derived nitric oxide production in patients undergoing ASD device closure. Circulation supp 98(17): I 38. AHA 71st Scientific Session, Dallas, TX, November 9, 1998.

12. Amin Z, Reddy MH, McElhinney DB, Teitel DT, Hanley FL, Moore P. Transcatheter interventions after one stage unifocalization for pulmonary atresia with ventricular septal defect: are stenoses native or anastomotic? Circulation supp 98(17): I 62. AHA 71st Scientific Session, Dallas, TX, November 9, 1998.

13. Moore P, Benson LN, Berman W, Cetta F, Hellenbrand WE, Latson LA, Lock JE, Mullins CE, Orsmond GS, Rome J, Zahn E. CardioSEAL device closure of secundum ASDs: How effective is it? Circulation supp 98(17): I 754. AHA 71st Scientific Session, Dallas, TX, November 11, 1998.

14. Moore P, Owada C, Teitel DF. Intermediate follow up results of 0.052” coil closure of large PDA. JACC 1999, 33 (supplementA):526A. ACC 48th Scientific Session, New Orleans, LA, March 8th 1999.

Page 21: PHILLIP MOORE M.D

21

15. Simpson JM, Teitel DF, Moore P. Complications of cardiac catheterization in infants weighing < 2.5 kg: Analysis of 103 consecutive cases. JACC 1999, 33 (supplementA):520A. ACC 48th Scientific Session, New Orleans, LA, March 7th 1999.

16. Tworetzky W, Teitel DF, Moore P. Balloon coarcplasty in infants after surgery for hypoplastic left heart syndrome. Catheterization and cardiovascular diagnosis, supplement May 1999. 22nd Annual SCA&I meeting, Monterey, CA, May 13, 1999.

17. Allan C, Teitel DF, Feinstein J, Moore P. The hemodynamic effects of increased cardiac demand on moderate aortic stenosis in children. Catheterization and cardiovascular diagnosis, supplement May 1999. 22nd Annual SCA&I meeting, Monterey, CA, May 14, 1999.

18. Burch G, Owada C, Teitel D, Moore P. Transcatheter therapy for patent ductus arteriosus in the adult. JACC 2000, 35 (supplement A) 497A. ACC 49th Scientific Session, Aneheim, CA, March 12, 2000.

19. Vranicar M, Teitel D, Moore P. Stenting of severely hypoplastic pulmonary arteries in pulmonary atresia with ventricular septal defect following early repair. JACC 2000, 35 (supplement A) 519A. ACC 49th Scientific Session, Aneheim, CA, March 15, 2000

20. Kuehne T, Saeed M, Reddy G, Akbary H, Vranicar M, Teitel D, Higgins C, Moore P. Effects of chronic right ventricular volume overload on left and right ventricular function: Assessment with MRI and conductance catheter in a growing closed chest animal model. Society for Pediatric Research, Baltimore, MD, April 30, 2001.

21. Moon-Grady AJ, Teitel DF, Hanley FL, Moore P. Ductus associated proximal pulmonary artery stenosis in patients with right heart obstructive lesions: Does the magnitude of the problem justify a change in management? 3rd World Congress of Pediatric Cardiology, Toronto, Canada. May 28, 2001

22. Kuehne T, Gleason K, Saeed M, Reddy G, Turner D, Teitel D, Higgins C, Moore P. Effects of chronic right ventricular volume and pressure overload on left and right ventricular function: Assessment with MRI and conductance catheter in a growing closed chest animal model. American Heart Association Scientific Sessions, Aneheim, CA, Nov 12, 2001.

23. Kuehne T, Saeed M, Reddy G, Gleason K, Turner D, Teitel D, Moore P, Higgins C. MRI guided deployment and post-interventional assessment of endovascular stents in the pulmonary position in growing swine. At the Society for Cardiovascular MRI, Lake Buena Vista FL, Jan 26, 2002.

24. Kuehne T, Gleason K, Saeed M, Reddy G, Turner D, Teitel D, Higgins C, Moore P. Right ventricular volume vs. pressure volume overload in growing swine: a study using MRI and the conductance catheter. At the International Symposium On

Page 22: PHILLIP MOORE M.D

22

Ventricular Function And Failure Form Mice To Man. Maastricht, NL. Jan 19, 2002.

25. Turner D, Teitel DF, Moore P. CardioSEAL device closure of multiple atrial septal defects with and without atrial septal aneurysm. At the American College of Cardiology 51st Scientific Session, March 6th, 2002, Atlanta, GA.

26. Kuehne T, Moore P, Saeed M, Gleason K, Weber O, Turner D, Teitel DF, Higgins CB. Magnetic resonance Imaging guided deployment and post-interventional assessment of endovascular stents in the pulmonary position in swine. At the American College of Cardiology 51st Scientific Session, March 6th, 2002, Atlanta, GA.

27. Divakaruni M S, Moore P. Is echocardiographic guidance necessary for device closure of patent foramen ovale? At the America College of Cardiology 52nd Scientific Session, Aril 1, 2003, Chicago IL.

28. Schalla S, Saeed M, Higgins C B, Weber O, Martin A, Moore P. Transcatheter Atrial Septal Defect Closure in an Animal Model: Assessment and Validation with Magnetic Resonance Imaging. At the American College of Cardiology 52nd Scientific Session, Aril 1, 2003, Chicago IL.

29. Schalla S, Saeed M, Higgins C B, Weber O, Martin A, Moore P. MR guided cardiac cathetrization of atrial septal defect in a swine model. At the Society for Cardiac and Interventions Scientific Session May 8, 2003, Boston, MA.

30. Moore P, Forbes T, Zahn E, Amin Z, Hijazi Z, Cheatham J, Hagler D, Ebeid M, Sievert H, Qureshi S, Fagan T, Hellenbrand W. (Congenitial Cardiovascular Interventional Study Consortium). Intermediate follow-up of Native and Recurrent Coarctation Stent Repair: A Multi-Institutional Study. At the American Heart Association Scientific Sessions, Nov9th, 2004, New Orleans, LA.

31. Kahwaji I, Teitel DF, Stanger P, Moore P. Symptomatic atrial septal defects in children under 2 years of age: To close or not to close? At the American College of Cardiology 54nd Scientific Session, March 5, 2005, Orlando, FL.

CURRENT RESEARCH (2003- 2004) A. Active Clinical Human Research:

1. Comparison of the cutting balloon with high pressure dilation of segmental pulmonary artery stentosis. (contingent CHR approval pending final modifications). This is a multi-center FDA approved randomized trial evaluating a new balloon dilation catheter with small razor blades which score the vessel intima and improve the ability to dilate stenotic blood vessels. Segmental pulmonary artery stenosis seen in congenital heart disease are particularly resistant to balloon dilation repair with limited other therapeutic options. Patient enrollment should begin 9/04.

2. “Evaluation of the safety and efficacy of the septal repair device in patients with secundum atrial septal defect (ASD)”(H7276-13240-06A). This is an FDA

Page 23: PHILLIP MOORE M.D

23

approved multicenter prospective clinical trial evaluating catheter device closure of atrial septal defects in children and adults. New patient enrollment is complete with final follow up data just finishing.

3. “Evaluation of the safety and efficacy of septal repair device closure of intracardiac defects in high risk patients”( H7276-14063-05A). This is an FDA approved multicenter prospective clinical trial evaluating catheter device closure of intracardiac defects, such as fenestrated Fontan, muscular VSDs, or large PDAs, in patients who are high risk for surgical repair. New patient enrollment is complete as is follow up data. Studies 1 and 2 have been instrumental in FDA approval of ASD and PFO device closure that is rapidly becoming the therapeutic procedure of choice for treatment replacing more traditional and costly surgical therapies. 4. “MRI evaluation of coarctation before and immediately after stent repair : Effect on collateral flow”. This is a prospective clinical study being done in conjunction with the department of Radiology assessing the immediate effects of stent repair of coarctation on blood flow through collateral vessels. Enrollment is complete. Patients will now be reevaluated at 1 and 2 year follow up for vascular changes related to stent implantation. B. Active Animal / Physiology Research: 1. "Effects of pulmonary insufficiency and stenosis on bi-ventricular function” (A7276-16580-01-03). We are currently in stage three of this protocol having completed evaluation of isolated insufficiency and combined insufficiency and stenosis effects on biventricular function in growing swine. We will now evaluate the timing of ventricular injury and its reversibility after the development of insufficiency using a transvenously implantable valved stent. Animals experiments for the third stage will begin this winter. 2. “Stent placement in the ductus arteriosus to provide controlled pulmonary blood flow in an animal model” (A7276-20213-01). This study evaluates placement of a newly developed covered stent in the ductus arteriosus of newborn piglets in an attempt to maintain ductal patentcy and limit pulmonary blood flow to safe levels for up to three months. This has potential application to infants with complex heart diseas e to reduce their need for surgery. This protocol includes in-vitro modeling as well as in-vivo stent implantation. Preliminary work has been done in vitro and in-vivo. This study is in progress. 3. “Magnetic Resonance Evaluation of Coarctation of the Aorta after Percutaneous Stent Repair in a Swine Model (A7276-24340-01). This study evaluates ventricular – arterial coupling and the effect of acute relief of aortic obtruction with stent repair. It also evaluates the ability to perform stent repair solely under MRI guidance. This study is in progress. Recent Publications of Greatest Significance: (numbers correspond to original reports on CV)

Page 24: PHILLIP MOORE M.D

24

Developed the ideas for these clinical research projects, facilitated pediatric cardiology fellow involvement, performed a majority of the procedures and assisted with fellow manuscript preparation: 45. Kung, G. C., P. Moore, McElhinney DB, Teitel DF.. (2003). Retrograde

Transcatheter Coil Embolization of Congenital Coronary Artery Fistulas in Infants and Young Children. Pediatr Cardiol.2003:24(5)448-53.

46. Thompson J, Moore P, Teitel D F. Pulmonary venous wedge pressures accurately predict pulmonary arterial pressures in children with single ventricle physiology. Pediatric Cardiol 2003:24(6)531-7.

Developed the idea/protocol for these animal physiology projects, generated research fellow involvement, facilitated interdepartmental integration, supervised experiments, and assisted with fellow manuscript preparation: 43. Kuehne T, Saeed M, Higgins CB, Gleason K, Krombach GA, Weber O, Martin A,

Turner D, Teitel DF, Moore P. MRI guided deployment and post-interventional assessment of endovascular stents in the pulmonary position in swine. Radiology, 2003: 226(2) 475-81.

48. Kuehne T, Saeed M, Gleason K, Turner D, Teitel DF, Higgins CB, Moore P. The Effects of Pulmonary Insufficiency on Biventricular Pump and Muscle Function in the Developing Heart of Young Growing Swine. Circulation 2003; 108: 2007-13.

49. Schalla S, Saeed M, Higgins CB, Martin A, Weber O, Moore P. Magnetic Resonance guided cardiac catheterization in a swine model of atrial septal defect. Circulation. 2003; 108: 1865-70.